Literature DB >> 31388274

Treatment Related Acute Myeloid Leukemia in Breast Cancer Survivors: A Single Institutional Experience.

Ilavarasi Vanidassane1, Ajay Gogia1, Vinod Raina2, Ritu Gupta3.   

Abstract

Entities:  

Year:  2019        PMID: 31388274      PMCID: PMC6646478          DOI: 10.1007/s12288-019-01078-w

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  5 in total

1.  Secondary hematological malignancies after breast cancer chemotherapy.

Authors:  Myung Joon Park; Yeon Hee Park; Heui June Ahn; Won Choi; Kwang Hyun Paik; Jung Min Kim; Yoon Hwan Chang; Baek-Yeol Ryoo; Sung Hyun Yang
Journal:  Leuk Lymphoma       Date:  2005-08

2.  Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.

Authors:  Dawn Hershman; Alfred I Neugut; Judith S Jacobson; Jian Wang; Wei-Yann Tsai; Russell McBride; Charles L Bennett; Victor R Grann
Journal:  J Natl Cancer Inst       Date:  2007-02-07       Impact factor: 13.506

3.  Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study.

Authors:  Mike G Martin; John S Welch; Jingqin Luo; Matthew J Ellis; Timothy A Graubert; Matthew J Walter
Journal:  Breast Cancer Res Treat       Date:  2009-03-26       Impact factor: 4.872

4.  Acute leukemia/myelodysplastic syndrome as a sequelae of carcinoma breast: a report of five cases from north India.

Authors:  Prateek Bhatia; Reena Das; Jasmina Ahluwalia; Pankaj Malhotra; Neelam Varma; S Varma; S C Sharma; Gurjeewan Garewal
Journal:  Indian J Pathol Microbiol       Date:  2009 Apr-Jun       Impact factor: 0.740

5.  Incidence of acute myeloid leukemia after breast cancer.

Authors:  Caterina Giovanna Valentini; Luana Fianchi; Maria Teresa Voso; Morena Caira; Giuseppe Leone; Livio Pagano
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-12-22       Impact factor: 2.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.